Citations

Mayo Clinic

Showing 10 of 108537 citations.

Cochlear Implantation in Patients With Osteolytic Labyrinthitis: A Case Series
Thedinger, William B., Dornhoffer, James R. , Merlino, Dante J. , Lane, John I. , Carlson, Matthew L. , Kircher, Matthew L.

Otology & Neurotology | May 10, 2024 | Volume: 45 | Issue: 5 | Pages: e406-e410

10.1097/mao.0000000000004193 | PMID 38728556 Get It

Objective To describe the rare process of osteolytic labyrinthitis, previously referred to as labyrinthine sequestrum, which involves progressive obliteration of the bony and membranous labyrinth with eventual supplantation with soft tissue and, in some cases, bony sequestrum. Patients Three patients with diverse presentations of osteolytic labyrinthitis from two tertiary care academic medical centers. Intervention(s) Case series report analyzing the relevant clinical, radiologic, pathologic, and surgical data on our patients with osteolytic labyrinthitis and comparing these index cases to the existing literature. Main Outcome Measure(s) We describe the varying image findings seen in osteolytic labyrinthitis on computed tomography and magnetic resonance imaging. Also, we report successful surgical intervention and hearing rehabilitation with cochlear implantation in patients with osteolytic labyrinthitis. Results Our three patients presented with profound sudden sensorineural hearing loss and vertigo consistent with labyrinthitis. None of the three patients had a history of chronic otitis media. Imaging workup revealed varying degrees of erosion to the otic capsule bone demonstrating the spectrum of disease seen in osteolytic labyrinthitis. Although two cases showed osteolytic changes to the semicircular canals and vestibule, the first case revealed frank bony sequestrum within the obliterated labyrinth. The three cases were taken for surgical debridement and cochlear implantation. Conclusions We propose the new term, osteolytic labyrinthitis—previously referred to as labyrinthine sequestrum—to describe the rare spectrum of disease characterized by destruction of the osseous and membranous labyrinth and potential supplantation with bony sequestrum. Cochlear implantation is a viable option in selected patients with osteolytic labyrinthitis.
Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation
Khandalavala, Karl R. , Herberg, Hans A., Kay‐Rivest, Emily , Moore, Lindsay S. , Marinelli, John P. , Lund‐Johansen, Morten , Kosaraju, Nikitha , Lohse, Christine M. , Kutz, Walter, Maria, Peter L. Santa , Golfinos, John G. , Carlson, Matthew L. , Tveiten, Øystein Vesterli , Link, Michael J. , Yancey, Kristen L. , Kondziolka, Douglas

Otology & Neurotology | May 10, 2024 | Volume: 45 | Issue: 5 | Pages: 587-593

10.1097/mao.0000000000004189 | PMID 38728563 Get It

Objective To describe outcomes of patients with sporadic vestibular schwannoma (VS) who underwent repeat stereotactic radiosurgery (SRS) after primary SRS failure. Study Design Multi-institutional historical cohort study. Setting Five tertiary care referral centers. Patients Adults ≥18 years old with sporadic VS. Intervention Primary and repeat treatment with SRS. Main Outcome Measure Microsurgery-free survival after repeat SRS. Results Across institutions, 32 patients underwent repeat SRS after primary SRS. Most patients (74%) had tumors with cerebellopontine angle extension at primary SRS (median size, 13.5 mm [interquartile range, 7.5–18.8] mm). After primary SRS, patients underwent repeat SRS at a median of 4.8 years (interquartile range, 3.2–5.7 yr). For treatment modality, 30 (94%) patients received gamma knife for primary treatment and 31 (97%) patients received gamma knife as their repeat treatment. Median tumor volume increased from 0.970 cm3 at primary SRS to 2.200 cm3 at repeat SRS. Facial nerve function worsened in two patients after primary SRS and in two patients after repeat SRS. There were no instances of intracranial complications after repeat SRS. Microsurgery-free survival rates (95% confidence interval; number still at risk) at 1, 3, and 5 years after repeat SRS were 97% (90–100%, 24), 84% (71–100%, 13), and 68% (48–96%, 6), respectively. There was one occurrence of malignancy diagnosed after repeat radiosurgery. Conclusion Overall, repeat SRS for sporadic VS has comparable risk profile, but lower rates of tumor control, compared with primary SRS.
Stapedotomy Versus Cochlear Implantation for Far Advanced Otosclerosis: Insights From a Patient With Matched Preoperative and Postoperative Function
Khandalavala, Karl R. , Dornhoffer, Jim R., Lane, John I. , Carlson, Matthew L.

Otology & Neurotology | May 10, 2024 | Volume: 45 | Issue: 5 | Pages: e381-e384

10.1097/mao.0000000000004197 | PMID 38728553 Get It

Objective To examine patient preference after stapedotomy versus cochlear implantation in a unique case of a patient with symmetrical profound mixed hearing loss and similar postoperative speech perception improvement. Patients An adult patient with bilateral symmetrical far advanced otosclerosis, with profound mixed hearing loss. Intervention Stapedotomy in the left ear, cochlear implantation in the right ear. Main Outcome Measure Performance on behavioral audiometry, and subjective report of hearing and intervention preference. Results A patient successfully underwent left stapedotomy and subsequent cochlear implantation on the right side, per patient preference. Preoperative audiometric characteristics were similar between ears (pure-tone average [PTA] [R: 114; L: 113 dB]; word recognition score [WRS]: 22%). Postprocedural audiometry demonstrated significant improvement after stapedotomy (PTA: 59 dB, WRS: 75%) and from cochlear implant (PTA: 20 dB, WRS: 60%). The patient subjectively reported a preference for the cochlear implant ear despite having substantial gains from stapedotomy. A nuanced discussion highlighting potentially overlooked benefits of cochlear implants in far advanced otosclerosis is conducted. Conclusion In comparison with stapedotomy and hearing aids, cochlear implantation generally permits greater access to sound among patients with far advanced otosclerosis. Though the cochlear implant literature mainly focuses on speech perception outcomes, an underappreciated benefit of cochlear implantation is the high likelihood of achieving “normal” sound levels across the audiogram.
The vital role of clinical pharmacy services within the hospital at home interdisciplinary team
Webster, Leah W., Gernhard, Chloe, Peinovich, Margaret, Wachter, Corey, Derleth, Brett M, Webster, Leah Whitman, Derleth, Brett, Peinovich, Margaret , Wachter, Corey J.

American Journal of Health-System Pharmacy | May 10, 2024 | Volume: 81 | Issue: 17 | Pages: e478-e488

10.1093/ajhp/zxae107 | PMID 38727687 Get It

Abstract Purpose Hospital at home (HaH) program development, spurred by hospital congestion during the COVID-19 pandemic, is moving from a novel idea to a standard of inpatient practice. Understanding pharmacy’s clinical role in the HaH patient care team is exceedingly important as programs across the country continue to develop, implement, and expand. The purpose of this study is to describe how clinical pharmacy services are currently provided for home hospital patients and to explain the vital role of pharmacists within the HaH care team. Description A descriptive study was designed to evaluate pharmacy services provided for home hospital patients from January 1, 2023, to February 28, 2023. Prior to the study period, a focused group of pharmacists routinely active in HaH patient care met to define a standard process for documenting pharmacy services using an electronic documentation system (i-Vent) within the EHR. During the study period, a total of 221 patients were admitted to home hospital at either site representing 3,258 inpatient medication orders with 2,997 medication administrations. Pharmacists signed 903 progress notes and documented 561 interventions across all types. The top 3 pharmacy intervention types were drug administration change (37%), medication reconciliation (29%), and antimicrobial stewardship (15%). Each of the top 3 types were further evaluated by subtype. Conclusion Documented pharmacy services encompassed a variety of intervention types. The overwhelming majority of patients admitted to the program received pharmacy consultative services, demonstrating how pivotal pharmacists are to the operational success of these programs and clinical care of HaH patients. More research is needed to expose pharmacy potential and facilitate growth for pharmacists practicing in HaH programs.
Comparison of the pleiotropic effect of atorvastatin and rosuvastatin on postmenopausal changes in bone turnover: A randomized comparative study
Braszak-Cymerman, Anna , Walczak‐Gałęzewska, Marta , Ludziejewska, Aleksandra , Oduah, Mary-Tiffany , Bryl, Wiesław

Medicine | May 10, 2024 | Volume: 103 | Issue: 19 | Pages: e38122

10.1097/md.0000000000038122 | PMID 38728464 Get It

Background: Statins are the first-line treatment for dyslipidemia, which is a major modifiable risk factor for atherosclerotic cardiovascular disease. Studies have shown that in addition to the beneficial lipid-lowering effect, statins also exhibit a number of pleiotropic effects that may find application in other diseases, including osteoporosis. This study aimed to assess the effect of statins on bone turnover, as measured by the concentration of bone turnover markers, and to compare the effect of atorvastatin as a lipophilic statin and rosuvastatin as a hydrophilic statin. Methods: This study included 34 postmenopausal women aged < 65 years with newly diagnosed dyslipidemia requiring statin therapy. Patients were randomly assigned to receive a statin drug. Statins were initiated at standard doses of 5 to 10 mg of rosuvastatin and 20 mg of atorvastatin. The levels of C-terminal telopeptide of type I collagen as a bone resorption marker and N-terminal propeptide of procollagen type I as a marker of bone formation, lipid concentrations and other biochemical parameters were assessed at baseline and after 6 and twelve months of treatment. Results: There were no statistically significant differences between the levels of bone turnover markers before and 6 months after statin implementation ( P > .05) - for all patients or subgroups according to statin use. Analysis of the results showed that after 12 months, there was a statistically significant decrease in N-terminal propeptide of procollagen type I concentration in all subjects ( P = .004). By statin subgroup, a statistically significant decrease in N-terminal propeptide of procollagen type I was observed only in patients receiving rosuvastatin ( P = .012) and not in those receiving atorvastatin ( P = .25). Moreover, changes in bone turnover markers did not correlate with changes in lipid concentrations. Conclusions: These results may indicate the superiority of atorvastatin over rosuvastatin in inhibiting adverse changes in bone turnover in postmenopausal women. Confirmed by studies involving a larger population, the observed differences might find particular applications in clinical practice, and the choice of atorvastatin over rosuvastatin for women could be considered in the early postmenopausal period to reduce the risk of osteoporosis and subsequent osteoporotic fractures.
Evaluating the Ability of Brachial Plexus-Injured Patients to Control an Externally Powered (Myoelectric) Hand Prosthesis
Lee, Ellen Y. , NELSON, A. WENDELL , Sampson, Brandon P. , Smither, F. Clay , Pulos, Nicholas , Bishop, Allen T. , Spinner, Robert J. , Shin, Alexander Y. , Shin, Alexander Y , Bishop, Allen T , Pulos, Nicholas

Journal of Bone and Joint Surgery | May 10, 2024 | Volume: 106 | Issue: 24 | Pages: 2375-2382

10.2106/jbjs.23.00938 | PMID 38728379 Get It

Background: Restoration of hand function after traumatic brachial plexus injury (BPI) remains a formidable challenge. Traditional methods such as nerve or free muscle transfers yield suboptimal results. Advancements in myoelectric prostheses, characterized by novel signal acquisition and improved material technology, show promise in restoring functional grasp. This study evaluated the ability of adults with a BPI injury to control an externally powered prosthetic hand using nonintuitive signals, simulating the restoration of grasp with a myoelectric prosthesis. It also assessed the effectiveness of a comprehensive multidisciplinary evaluation in guiding treatment decisions. Methods: A multidisciplinary brachial plexus team assessed adults with compromised hand function due to BPI. The feasibility of amputation coupled with fitting of a myoelectric prosthesis for grasp reconstruction was evaluated. Participants' ability to control a virtual or model prosthetic hand using surface electromyography (EMG) as well as with contralateral shoulder motion-activated linear transducer signals was tested. The patient’s input and injury type, along with the information from the prosthetic evaluation, were used to determine the reconstructive plan. The study also reviewed the number of participants opting for amputation and a myoelectric prosthetic hand for grasp restoration, and a follow-up survey was conducted to assess the impact of the initial evaluation on decision-making. Results: Of 58 subjects evaluated, 47 (81%) had pan-plexus BPI and 42 (72%) received their initial assessment within 1 year post-injury. Forty-seven patients (81%) could control the virtual or model prosthetic hand using nonintuitive surface EMG signals, and all 58 could control it with contralateral uniscapular motion via a linear transducer and harness. Thirty patients (52%) chose and pursued amputation, and 20 (34%) actively used a myoelectric prosthesis for grasp. The initial evaluation was informative and beneficial for the majority of the patients, especially in demonstrating the functionality of the myoelectric prosthesis. Conclusions: The study indicates that adults with traumatic BPI can effectively operate a virtual or model myoelectric prosthesis using nonintuitive control signals. The simulation and multidisciplinary evaluation influenced informed treatment choices, with a high percentage of patients continuing to use the myoelectric prostheses post-amputation, highlighting its long-term acceptance and viability. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
Qin, Chuan , Zhang, Min , Mou, Dapeng , Zhou, Luo‐Qi , Dong, Ming‐Hao , Huang, Liang , Wang, Wen , Cai, Song-Bai , You, Yun‐Fan , Shang, Ke , Xiao, Jun , Wang, Di , Li, Chunrui , Hao, Yi , Wu, Long‐Jun , Bu, Bi-Tao, Wang, Wei , Li, Chun-Rui , Heming, Michael , Wu, Long-Jun , Meyer Zu Hörste, Gerd , Dong, Chen , Bu, Bi-Tao , Tian, Dai-Shi , Wang, Wei , Wang, Wen , Tian, Dai‐Shi

Science Immunology | May 10, 2024 | Volume: 9 | Issue: 95 | Pages: No page available

10.1126/sciimmunol.adj9730 | PMID 38728414 Get It

Chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of neurological autoimmune diseases is promising, but CAR T cell kinetics and immune alterations after treatment are poorly understood. Here, we performed single-cell multi-omics sequencing of paired cerebrospinal fluid (CSF) and blood samples from patients with neuromyelitis optica spectrum disorder (NMOSD) treated with anti–B cell maturation antigen (BCMA) CAR T cells. Proliferating cytotoxic-like CD8 + CAR T cell clones were identified as the main effectors in autoimmunity. Anti-BCMA CAR T cells with enhanced features of chemotaxis efficiently crossed the blood-CSF barrier, eliminated plasmablasts and plasma cells in the CSF, and suppressed neuroinflammation. The CD44-expressing early memory phenotype in infusion products was potentially associated with CAR T cell persistence in autoimmunity. Moreover, CAR T cells from patients with NMOSD displayed distinctive features of suppressed cytotoxicity compared with those from hematological malignancies. Thus, we provide mechanistic insights into CAR T cell function in patients with neurological autoimmune disease.
D89. Nipple Areolar Malposition versus Ideal Position after Nipple-Sparing Mastectomy Reconstruction
Mendoza, Alessa Mikaela, Hochwald, Alex, Rinker, Brian, TerKonda, Sarvam P. , McLaughlin, Sarah A. , Ho, Olivia A. , Li, Zhuo , Borna, Sahar , Forte, Antonio J. , Jakub, James W.

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 111-111

10.1097/01.gox.0001018840.30925.2a Get It

D147. Cost Effectiveness of Incisional Negative Pressure Wound Therapy in Penile Inversion Vaginoplasty
Sanchez, Maria V. Rios, Figueroa, Nicole Sanchez, Martinez‐Jorge, Jorys, Figueroa, Nicole Gabriela Sanchez , Sanchez Figueroa, Nicole Gabriela , Fahradyan, Vahe

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 137-137

10.1097/01.gox.0001019176.36857.f4 Get It

D155. Exploring the Efficacy of a Novel Platysma Muscle Flap in Rat Models for Advancing Facial Paralysis Reconstruction Research
Millesi, Elena , Wang, Huan , Radtke, Christine , Mardini, Samir

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 141-141

10.1097/01.gox.0001019208.82981.1f Get It